Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Final data from a landmark study on PainTEQ's posterior approach SI joint fusion with the LinQ™ implant revealed improved pain and function scores...
PainTEQ, a leading innovator in minimally invasive sacroiliac (SI) joint dysfunction treatments, has achieved a significant milestone with the...
On December 4, 2023, Patent Trial and Appeal Board (PTAB) issued a final written decision in an inter partes review (IPR) (case No. IPR2023-00451)...
The Centers for Medicare & Medicaid Services (CMS) has finalized its decision to establish payment rates for PainTEQ's new Current Procedural...
The American Medical Association (AMA) has announced the release of the 2024 CPT code set, which includes a new Category I CPT code for PainTEQ's...
PainTEQ, a leading innovator in minimally invasive sacroiliac (SI) joint dysfunction treatments, announced the release of its new Surgery-Ready...
PainTEQ, a market leader in minimally invasive posterior sacroiliac (SI) joint fusion procedures, today announced the closing of $35 million in...
The results of a comparative biomechanical analysis of the posterior sacroiliac (SI) joint fusion to the traditional lateral approach show that a...
PainTEQ, a fast-growing medical innovation company, announced that on May 24, 2023, the Patent Trial and Appeal Board (PTAB) issued a final written...
PainTEQ, a fast-growing medical innovation company and the creator of LinQ, a minimally invasive therapy for SI joint (SIJ) dysfunction, announced...
The American Medical Association (AMA) has announced a new Category 1 billing code specifically for posterior SI joint fusion, including PainTEQ's...
Cally Stanphill, Director of Talent Acquisition at PainTEQ, has been accepted into Forbes Human Resources Council, an invitation-only community for...
Prominent business magazine Inc. listed Tampa-based medical innovation company PainTEQ as #149 in their annual Inc. 5000 ranking of America's...
Preliminary data from the landmark SI joint fusion study of Tampa-based medical innovation company, PainTEQ, reveals that a posterior approach to SI...
It's not every day that you hear about a business practicing what they preach, but Tampa-based medical device company, PainTEQ, does just that. Their ...
PainTEQ, a Tampa-based medical technology innovator and creator of LinQ, minimally invasive therapy for SI joint (SIJ) dysfunction, announces two new ...
Preliminary data from the landmark SI joint fusion study of Tampa-based medical device company, PainTEQ, reveals that a posterior approach to SI...
A biomechanical evaluation of the novel LinQ device revealed statistically significant fixation of the sacroiliac (SI) joint. Developed by...
PainTEQ, the creator of LinQ, a minimally invasive therapy for SI joint (SIJ) dysfunction, announced the appointment of Michael Enxing, former Chief...
A new multicenter real-world study of PainTEQ's LinQ device reflected long-term success and safety in treating sacroiliac (SI) joint dysfunction. The ...
PainTEQ, a fast-growing,Tampa-based medical device company focused on treating sacroiliac (SI) joint dysfunction, announced the award of three new...
An independent study introduced the concept of a posterior approach to SI (sacroiliac) joint fusion as a feasible adjunct and salvage technique for...
Prominent business magazine Inc. today featured Tampa-based medical technology company PainTEQ as #95 in their annual "Inc. 5000" ranking of...
Medical device innovator PainTEQ announced the appointment of Timothy Deer, MD, DABPM, to its Scientific Advisory Board. Deer is president and CEO of ...
In the wave of innovative medical technology, PainTEQ, in partnership with Evolve Restorative Center in Santa Rosa, California and Celeri Health in...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.